The patented electron beam technology is the technology of choice for product sterilization, electronic pasteurization of food, and a variety of other industry needs. Because the proprietary technology uses ordinary electricity, it's more efficient, requires significantly less processing time, and poses no known environmental risks. More than 50 percent of Isotron's revenue is derived from the sterilization of healthcare products. The food packaging, cosmetics, pharmaceutical industries, and others also use Isotron's microbe control services. Electron beam irradiation of plastics and other polymeric materials provides key benefits to manufacturers and suppliers because it enhances the various performance characteristics of these compounds.
Titan markets the leading technology for the electronic pasteurization of food products.
The company's three other core businesses develop and deploy communications and information technology solutions and services. The statements contained in this release, which are not historical facts, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Examples of such forward looking statements include the Company's belief that it is a leader in electron beam technology. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. These risks and uncertainties include the risks associated with the Company's entry into new commercial businesses and new markets such as the food pasteurization market that require the company to develop demand for its product, its ability to execute its spin off strategy, its ability to access the capital markets, dependence on continued funding of U.S. Department of Defense and federal civilian agency program, contract termination risks, risks associated with acquiring other companies, including integration risks, the risks of doing business in developing countries and international markets including foreign currency risks, and other risks described in the Company's Securities and Exchange Commission filings.